Previous studies have reported that ERβ induced alteration of miRs in colon cancer (Table 2), resulting in changes of miRs mediated cellular pathophysiology, which in turn could provide cancer‐protective features.26, 35, 36. The gene discussed is ESR2; the disease is cancer.